ABOUT THE PROGRAM
Positioning promising biomedical technologies to address UNDER SERVED healthcare needs
The Columbia Biomedical Technology Accelerator (formerly the Columbia-Coulter Translational Research Partnership) aims to catalyze the advancement of biomedical technologies by providing funding, education, resources and mentorship to teams of clinicians, engineers and scientists working to develop solutions to clinical unmet needs, with the ultimate goal of bringing innovative research out of the lab to benefit society.
Project support is expected to serve as a bridge to commercial investment, with awards granted to perform specific tasks needed to validate a commercial hypothesis (vs. a scientific hypothesis).
Funding for the program has been generously provided by the Dept of Biomedical Engineering at the Fu Foundation School of Engineering and Applied Science, the Depts of Surgery, Orthopedic Surgery and Radiology at Columbia University Medical Center, and Columbia Technology Ventures, the technology transfer office of Columbia University.
Over $700,000 of funding is available to support selected projects, with an additional $300,000 worth of in-kind additional resources (marketing, regulatory, reimbursement, and legal).
Selected teams are connected with experts in regulatory strategy, intellectual property counsel, reimbursement, marketing identifying and product development.
Funded project teams work with a commercialization team as active partners, and meet regularly with Program Management to review technical and business milestones.